P V Grootendorst

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. pmc Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs
    P V Grootendorst
    Department of Clinical Epidemiology and Biostatistics, McMaster University, and Centre for Evaluation of Medicines, St Joseph s Hospital, Hamilton, Ont
    CMAJ 165:1011-9. 2001
  2. ncbi request reprint Beneficiary cost sharing under Canadian provincial prescription drug benefit programs: history and assessment
    Paul Grootendorst
    McMaster University and Centre for Evaluation of Medicines, Hamilton, Ontario, Canada
    Can J Clin Pharmacol 9:79-99. 2002
  3. ncbi request reprint Health care policy evaluation using longitudinal insurance claims data: an application of the panel Tobit estimator
    P V Grootendorst
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada
    Health Econ 6:365-82. 1997
  4. ncbi request reprint Effect of copayments on drug use in the presence of annual payment limits
    George Kephart
    Department of Community Health and Epidemiology, Dalhousie University, Halifax, NS, Canada
    Am J Manag Care 13:328-34. 2007
  5. ncbi request reprint A re-examination of the impact of reference pricing on anti-hypertensive drug plan expenditures in British Columbia
    Paul Grootendorst
    Faculty of Pharmacy, University of Toronto, Toronto, Ont, Canada
    Health Econ 15:735-42. 2006
  6. ncbi request reprint Impact of administrative restrictions on antibiotic use and expenditure in Ontario: time series analysis
    Deborah Marshall
    Innovus Research Inc, 1016 A Sutton Drive, Burlington, Ontario L7L 6B8, Canada
    J Health Serv Res Policy 11:13-20. 2006
  7. ncbi request reprint Estimating the price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec, Canada
    Paul Contoyannis
    Centre for Health Economics and Policy Analysis, McMaster University, Canada
    Health Econ 14:909-23. 2005
  8. ncbi request reprint Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA
    Med Care 42:653-60. 2004
  9. ncbi request reprint The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada
    Sule Alan
    Department of Economics, York University, Toronto, Canada
    J Health Econ 21:805-26. 2002
  10. ncbi request reprint The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada
    Deborah A Marshall
    Centre for Evaluation of Medicines, 105 Main Street East, Level P1, Hamilton, ON L8N 1G6, Canada
    Health Policy 84:1-13. 2007

Detail Information

Publications14

  1. pmc Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs
    P V Grootendorst
    Department of Clinical Epidemiology and Biostatistics, McMaster University, and Centre for Evaluation of Medicines, St Joseph s Hospital, Hamilton, Ont
    CMAJ 165:1011-9. 2001
    ..We estimated the effect of reference-based pricing of nitrate drugs used for long-term prophylaxis on prescribing of and expenditures on nitrates and other anti-anginal drugs dispensed to senior citizens in British Columbia...
  2. ncbi request reprint Beneficiary cost sharing under Canadian provincial prescription drug benefit programs: history and assessment
    Paul Grootendorst
    McMaster University and Centre for Evaluation of Medicines, Hamilton, Ontario, Canada
    Can J Clin Pharmacol 9:79-99. 2002
    ..Each province has, however, provided coverage to senior citizens and social assistance recipients; some provinces have introduced drug coverage for the general public...
  3. ncbi request reprint Health care policy evaluation using longitudinal insurance claims data: an application of the panel Tobit estimator
    P V Grootendorst
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada
    Health Econ 6:365-82. 1997
    ..Little evidence of transitory effects to insurance coverage was found. Finally, the extension of insurance has made only a minor contribution to growth in seniors' drug use, relative to secular growth in drug use over time...
  4. ncbi request reprint Effect of copayments on drug use in the presence of annual payment limits
    George Kephart
    Department of Community Health and Epidemiology, Dalhousie University, Halifax, NS, Canada
    Am J Manag Care 13:328-34. 2007
    ....
  5. ncbi request reprint A re-examination of the impact of reference pricing on anti-hypertensive drug plan expenditures in British Columbia
    Paul Grootendorst
    Faculty of Pharmacy, University of Toronto, Toronto, Ont, Canada
    Health Econ 15:735-42. 2006
    ..We find that controlling for such factors reduces estimates of drug plan savings attributable to RP of the Calcium Channel Blockers by about half...
  6. ncbi request reprint Impact of administrative restrictions on antibiotic use and expenditure in Ontario: time series analysis
    Deborah Marshall
    Innovus Research Inc, 1016 A Sutton Drive, Burlington, Ontario L7L 6B8, Canada
    J Health Serv Res Policy 11:13-20. 2006
    ..Our objective was to determine the impact of this policy on the volume and cost of antibiotic prescribing...
  7. ncbi request reprint Estimating the price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec, Canada
    Paul Contoyannis
    Centre for Health Economics and Policy Analysis, McMaster University, Canada
    Health Econ 14:909-23. 2005
    ..Our preferred specification leads to expenditure elasticities that are in the low range of previous estimates (between -0.12 and -0.16). Naïve OLS estimates are between 1 and 4 times these magnitudes...
  8. ncbi request reprint Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA
    Med Care 42:653-60. 2004
    ..Critics argued that drug plan savings are offset by administrative costs and increased spending on other health services...
  9. ncbi request reprint The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada
    Sule Alan
    Department of Economics, York University, Toronto, Canada
    J Health Econ 21:805-26. 2002
    ..Such evidence may have relevance for predicting the redistributive effects of a potential national prescription drug plan for seniors in the US...
  10. ncbi request reprint The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada
    Deborah A Marshall
    Centre for Evaluation of Medicines, 105 Main Street East, Level P1, Hamilton, ON L8N 1G6, Canada
    Health Policy 84:1-13. 2007
    ..Ontario required physicians to submit the clinical indications for their use on the prescription. British Columbia required physicians to seek and receive prior authorisation from the drug plan...
  11. ncbi request reprint Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence
    Joel Lexchin
    School of Health Policy and Management at York University, Toronto, Canada
    Int J Health Serv 34:101-22. 2004
    ..Cost sharing also leads to patients foregoing essential medications and to a decline in health care status...
  12. ncbi request reprint Coding accuracy of administrative drug claims in the Ontario Drug Benefit database
    Adrian R Levy
    Centre for Health Evaluation and Outcome Sciences, St Paul s Hospital, Vancouver, Canada
    Can J Clin Pharmacol 10:67-71. 2003
    ....
  13. ncbi request reprint Validity of self-reported prescription drug insurance coverage
    Paul Grootendorst
    Faculty of Pharmacy, University of Toronto, Toronto, Ontario, M5S 2S2
    Health Rep 14:35-46. 2003
    ..This article assesses the validity of prescription drug insurance coverage as self-reported in the 1996/97 National Population Health Survey (NPHS)...
  14. ncbi request reprint Dental insurance, income and the use of dental care in Canada
    Taimur Bhatti
    Ontario Ministry of Health and Long Term Care, Toronto, Ontario, Canada
    J Can Dent Assoc 73:57. 2007
    ....